Monoclonal Antibody Treatments for COVID-19 (Bamlanivimab and Regeneron): The linked letter and referral form below are intended to provide updated information regarding the referral process and available Maryland infusion sites for the two FDA EUA-approved monoclonal antibody (mAb) treatments for COVID-19: bamlanivimab (Eli Lilly) and the antibody combination, casirivimab/imdevimab (Regeneron). Early data for these therapeutics suggest that they may reduce the risk of hospitalization for people at high risk who have tested positive for COVID-19 and have only mild to moderate symptoms.
The Maryland Department of Health is investigating cases of individuals who have developed severe lung illness with no clear infectious cause after using e-cigarettes, or “vaping.” Similar cases have been reported in other states across the United States and are described on the CDC Webpage. See Maryland information here.
On October 3, 2019, the Maryland Secretary of Health issued a clinical reporting order as the severe lung illness investigation continues. See the details of the directive and order here. Frederick County healthcare providers should call 301-600-1733 to notify the Frederick County Health Department if they have a patient they suspect of having a vaping-related illness.
Measles (April 2019)
Several cases of measles have been confirmed in Maryland. Please follow the guidance provided in the clinician letters below. Updated information can be found at the Maryland Department of Health website.